Couverture de JAMA Cardiology Author Interviews

JAMA Cardiology Author Interviews

JAMA Cardiology Author Interviews

De : JAMA Network
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

 Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.2025 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies. Hygiène et vie saine Maladie et pathologies physiques Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement

      Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement
      Dec 10 2025

      Interview with Alfred E. Buxton, MD, and Marie-France Poulin, MD, authors of Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement. Hosted by Kristen K. Patton, MD.

      Related Content:

      • Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement
      Afficher plus Afficher moins
      19 min
    • From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more

      From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more
      Sep 16 2025
      Special edition of the JAMA Editor's Summary featuring the JAMA Network articles published at the 2025 European Society of Cardiology Congress. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, with JAMA Executive Editor Gregory Curfman, MD, JAMA Senior Editor Philip Greenland, MD, and JAMA Cardiology Editor Robert O. Bonow, MD, MS. Related Content: Remote Screening for Asymptomatic Atrial FibrillationLong-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial FibrillationSystolic Blood Pressure and Microaxial Flow Pump–Associated Survival in Infarct-Related Cardiogenic ShockHelicobacter pylori Screening After Acute Myocardial InfarctionPhysiology-Guided Complete Revascularization in Older Patients With Myocardial InfarctionFractional Flow Reserve–Guided Complete vs Culprit-Only Revascularization in Non–ST-Elevation Myocardial Infarction and Multivessel DiseaseTranscatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate RiskSemaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection FractionBivalent RSV Prefusion F Protein–Based Vaccine for Preventing Cardiovascular Hospitalizations in Older AdultsHigh-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older AdultsRisk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza VaccineClonal Hematopoiesis and Risk of New-Onset Myocarditis and PericarditisParticipation of Women in Cardiovascular Trials From 2017 to 2023Prevalence, Determinants, and Time Trends of Cardiovascular Health in the WHO African Region
      Afficher plus Afficher moins
      38 min
    • Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure

      Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
      Sep 10 2025

      Interview with Frederick L. Ruberg, MD, and Mathew S. Maurer, MD, authors of Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. Hosted by Sadiya Khan, MD.

      Related Content:

      • Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
      Afficher plus Afficher moins
      18 min
    Aucun commentaire pour le moment